High throughput screening of protein formulation stability: Practical considerations

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 65, Issue 2, 2007, Pages 131-148

  Capelle, Martinus A H ^a   Gurny, Robert ^a   Arvinte, Tudor ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Aggregation; Fluorescence; High throughput screening; Physical and chemical characterization; Protein formulation; Spectroscopy; Stability

Indexed keywords

TRASTUZUMAB;

CIRCULAR DICHROISM; DIFFERENTIAL SCANNING CALORIMETRY; FLUORESCENCE ANALYSIS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HIGH THROUGHPUT SCREENING; INFRARED SPECTROSCOPY; LIGHT SCATTERING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN ELECTROPHORESIS; RAMAN SPECTROMETRY; REVIEW; SPECTROSCOPY; ULTRAVIOLET SPECTROSCOPY; X RAY CRYSTALLOGRAPHY;

CALORIMETRY; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, LIQUID; CIRCULAR DICHROISM; DRUG EVALUATION, PRECLINICAL; DRUG STABILITY; ELECTROPHORESIS; FLUORESCENCE POLARIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HYDROGEN-ION CONCENTRATION; LIGHT; MASS SPECTROMETRY; PHARMACEUTICAL PREPARATIONS; PROTEINS; SCATTERING, RADIATION; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SPECTRUM ANALYSIS, RAMAN;

EID: 33845923234     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2006.09.009     Document Type: Review

References (166)

1. Walsh G. Biopharmaceutical benchmarks 2006. Nat. Biotechnol. 24 (2006) 769-776
2. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., Smith H.O., Yandell M., Evans C.A., Holt R.A., et al. The sequence of the human genome. Science 291 (2001) 1304-1351
3. Fermier A.M., Troisi J., Heritage E.C., Drexel M.A., Gallea P., and Swinney K.A. Powder dispensing robot for sample preparation. Analyst 128 (2003) 790-795
4. Kane N.R., Broce B., Gonzalez-Zugasti J., Lewis W.P., LeQuesne M., and Lemmo A.V. A system for dispensing sub-milligram doses of active pharmaceutical powders for early stage solubility assays. JALA 9 (2004) 218-227
5. Wong S.K., Lu Y., Heineman W., Palmer J., and Courtney C. Fully automated solid weighing workstation. J. Biomol. Screen. 10 (2005) 524-531
6. Hertzberg R.P., and Pope A.J. High-throughput screening: new technology for the 21st century. Curr. Opin. Chem. Biol. 4 (2000) 445-451
7. Sundberg S.A. High-throughput and ultra-high-throughput screening: solution- and cell-based approaches. Curr. Opin. Biotechnol. 11 (2000) 47-53
8. Knowles J., and Gromo G. A guide to drug discovery: target selection in drug discovery. Nat. Rev. Drug Discov. 2 (2003) 63-69
9. Fox S., Wang H., Sopchak L., and Khoury R. High throughput screening: early successes indicate a promising future. J. Biomol. Screen. 6 (2001) 137-140
10. Fox S., Wang H., Sopchak L., and Farr-Jones S. High throughput screening 2002: moving toward increased success rates. J. Biomol. Screen. 7 (2002) 313-316
11. Fox S., Farr-Jones S., Sopchak L., Boggs A., and Comley J. High-throughput screening: searching for higher productivity. J. Biomol. Screen. 9 (2004) 354-358
12. Lundqvist T. The devil is still in the details-driving early drug discovery forward with biophysical experimental methods. Curr. Opin. Drug Discov. Devel. 8 (2005) 513-519
13. Stefani M., and Dobson C.M. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 81 (2003) 678-699
14. Pellaud J., Schote U., Arvinte T., and Seelig J. Conformation and self-association of human recombinant transforming growth factor-beta3 in aqueous solutions. J. Biol. Chem. 274 (1999) 7699-7704
15. Nayar R., and Manning M.C. High throughput formulation: strategies for rapid development of stable protein products. In: Carpenter J.F., and Manning M.C. (Eds). Rational design of stable protein formulations: theory and practice (2002), Kluwer Academic/Plenum Publishers, New York 177-198
16. Brown M.B. The lost science of formulation. Drug Discov. Today 10 (2005) 1405-1407
17. Jaenicke R. Stability and stabilization of globular proteins in solution. J. Biotechnol. 79 (2000) 193-203
18. Cleland J.L., Lam X., Kendrick B., Yang J., Yang T.H., Overcashier D., Brooks D., Hsu C., and Carpenter J.F. A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody. J. Pharm. Sci. 90 (2001) 310-321
19. Parkins D.A., and Lashmar U.T. The formulation of biopharmaceutical products. Pharm. Sci. Technol. Today 3 (2000) 129-137
20. Chi E.Y., Krishnan S., Randolph T.W., and Carpenter J.F. Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation. Pharm. Res. 20 (2003) 1325-1336
21. Cleland J.L., Powell M.F., and Shire S.J. The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. Crit. Rev. Ther. Drug Carrier Syst. 10 (1993) 307-377
22. Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int. J. Pharm. 185 (1999) 129-188
23. Volkin D.B., Mach H., and Middaugh C.R. Degradative covalent reactions important to protein stability. In: Shirley B.A. (Ed). Methods in Molecular Biology. Protein Stability and Folding: Theory and Practice vol. 40 (1995), Humana Press Inc., Totowa, NJ 35-63
24. Manning M.C., Patel K., and Borchardt R.T. Stability of protein pharmaceuticals. Pharm. Res. 6 (1989) 903-918
25. Wang W. Protein aggregation and its inhibition in biopharmaceutics. Int. J. Pharm. 289 (2005) 1-30
26. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., Taddei N., Ramponi G., Dobson C.M., and Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416 (2002) 507-511
27. Wang W., and Kelner D.N. Correlation of rFVIII inactivation with aggregation in solution. Pharm. Res. 20 (2003) 693-700
28. Cudd A., Arvinte T., Das R.E., Chinni C., and MacIntyre I. Enhanced potency of human calcitonin when fibrillation is avoided. J. Pharm. Sci. 84 (1995) 717-719
29. Arvinte T. Concluding remarks: analytical methods for protein formulations. In: Jiskoot W., and Crommelin D.J. (Eds). Methods for Structural Analysis of Protein Pharmaceuticals (2005), AAPS Press, Arlington 661-666
30. Sethuraman A., and Belfort G. Protein structural perturbation and aggregation on homogeneous surfaces. Biophys. J. (2004)
31. Maa Y.F., and Hsu C.C. Aggregation of recombinant human growth hormone induced by phenolic compounds. Int. J. Pharm. 140 (1996) 155-168
32. Lee Y.C., Zocharski P.D., and Samas B. An intravenous formulation decision tree for discovery compound formulation development. Int. J. Pharm. 253 (2003) 111-119
33. A.L. Margolin, High throughput screening for protein formulations, WO Patent 2002035241 (2002).
34. Gupta S., and Kaisheva E. Development of a multidose formulation for a humanized monoclonal antibody using experimental design techniques. AAPS PharmSci. 5 (2003) E8
35. Arakawa T., Prestrelski S.J., Kenney W.C., and Carpenter J.F. Factors affecting short-term and long-term stabilities of proteins. Adv. Drug Deliv. Rev. 46 (2001) 307-326
36. Powell M.F., Nguyen T., and Baloian L. Compendium of excipients for parenteral formulations. PDA J. Pharm. Sci. Technol. 52 (1998) 238-311
37. Pikal M.J., Dellerman K.M., Roy M.L., and Riggin R.M. The effects of formulation variables on the stability of freeze-dried human growth hormone. Pharm. Res. 8 (1991) 427-436
38. Crowe J.H., and Crowe L.M. Preservation of mammalian cells-learning nature's tricks. Nat. Biotechnol. 18 (2000) 145-146
39. Eroglu A., Russo M.J., Bieganski R., Fowler A., Cheley S., Bayley H., and Toner M. Intracellular trehalose improves the survival of cryopreserved mammalian cells. Nat. Biotechnol. 18 (2000) 163-167
40. Chang B.S., and Hershenson S. Practical approaches to protein formulation development. In: Carpenter J.F., and Manning M.C. (Eds). Rational Design of Stable Protein Formulations: Theory and Practice (2002), Kluwer Academic/Plenum Publishers, New York 1-25
41. Mahler H.C., Muller R., Friebeta W., Delille A., and Matheus S. Induction and analysis of aggregates in a liquid IgG1-antibody formulation. Eur. J. Pharm. Biopharm. 59 (2005) 407-417
42. ICH, Guideline for industry: Quality of biotechnological products: stability testing of biotechnological/biological products, IFPMA, 1996, Geneva, International Conference on harmonisation.
43. Auer M., Moore K.M., Meyer-Almes F.J., Guenther R., Pope A.J., and Stoeckli K.A. Fluorescence correlation spectroscopy: lead discovery by miniaturized HTS. Drug Discov. Today 3 (1998) 457-465
44. Malik T.J. Buyers' guide to microplate readers. The Scientist 18 (2004) 34-36
45. Smith A. Screening for drug discovery: the leading question. Nature 418 (2002) 453-459
46. McGown E.L., and Hafeman D.G. Multichannel pipettor performance verified by measuring pathlength of reagent dispensed into a microplate. Anal. Biochem. 258 (1998) 155-157
47. Geiger G., Bernhagen J., Wagner E., Bisswanger H., Brunner H., and Vitzthum F. Standardized measurements and differential spectroscopy in microplates. Anal. Biochem. 296 (2001) 29-40
48. Zimmermann H.F., John G.T., Trauthwein H., Dingerdissen U., and Huthmacher K. Rapid evaluation of oxygen and water permeation through microplate sealing tapes. Biotechnol. Prog. 19 (2003) 1061-1063
49. Berg M., Undisz K., Thiericke R., Zimmermann P., Moore T., and Posten C. Evaluation of liquid handling conditions in microplates. J. Biomol. Screen. 6 (2001) 47-56
50. Clarke G.A., Feiglin M.N., King G.W., Bishop J., Skwish S., and Kath G.S. A simple automated solution for removing and applying sealing microplate lids. J. Biomol. Screen. 6 (2001) 333-338
51. Ritter N., and McEntire J. Determining protein concentration. Bio. Pharm. Int. (2002) 12-22
52. Kreusch S., Schwedler S., Tautkus B., Cumme G.A., and Horn A. UV measurements in microplates suitable for high-throughput protein determination. Anal. Biochem. 313 (2003) 208-215
53. Chapman E., and Wong C.H. A pH sensitive colorometric assay for the high-throughput screening of enzyme inhibitors and substrates: a case study using kinases. Bioorg. Med. Chem. 10 (2002) 551-555
54. Needleman I.G., Grahn M.F., and Pandya N.V. A rapid spectrophotometric assay for tetracycline in gingival crevicular fluid. J. Clin. Periodontol. 28 (2001) 52-56
55. Eckhardt B.M., Oeswein J.Q., Yeung D.A., Milby T.D., and Bewley T.A. A turbidimetric method to determine visual appearance of protein solutions. J. Pharm. Sci. Technol. 48 (1994) 64-70
56. Bevan C.D., and Lloyd R.S. A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. Anal. Chem. 72 (2000) 1781-1787
57. Frenchik M.D., McFaul S.J., and Tsonev L.I. A microplate assay for the determination of hemoglobin concentration. Clin. Chim. Acta 339 (2004) 199-201
58. Lavery P., Brown M.J., and Pope A.J. Simple absorbance-based assays for ultra-high throughput screening. J. Biomol. Screen. 6 (2001) 3-9
59. Zuck P., O'donnell G.T., Cassaday J., Chase P., Hodder P., Strulovici B., and Ferrer M. Miniaturization of absorbance assays using the fluorescent properties of white microplates. Anal. Biochem. 342 (2005) 254-259
60. Drake A.F. The measurement of electronic absorption spectra in the ultraviolet and visible. Methods Mol. Biol. 22 (1994) 173-182
61. Reetz M.T., Kuhling K.M., Hinrichs H., and Deege A. Circular dichroism as a detection method in the screening of enantioselective catalysts. Chirality 12 (2000) 479-482
62. Wallace B.A., and Janes R.W. Circular dichroism and synchrotron radiation circular dichroism spectroscopy: tools for drug discovery. Biochem. Soc. Trans. 31 (2003) 631-633
63. Clarke D.T., and Jones G. CD12: a new high-flux beamline for ultraviolet and vacuum-ultraviolet circular dichroism on the SRS, Daresbury. J. Synchrotron. Radiat. 11 (2004) 142-149
64. Miron S., Refregiers M., Gilles A.M., and Maurizot J.C. New synchrotron radiation circular dichroism end-station on DISCO beamline at SOLEIL synchrotron for biomolecular analysis. Biochim. Biophys. Acta 1724 (2005) 425-431
65. Woestenenk E.A., Hammarstrom M., Hard T., and Berglund H. Screening methods to determine biophysical properties of proteins in structural genomics. Anal. Biochem. 318 (2003) 71-79
66. Maxwell K.L., Bona D., Liu C., Arrowsmith C.H., and Edwards A.M. Refolding out of guanidine hydrochloride is an effective approach for high-throughput structural studies of small proteins. Protein Sci. 12 (2003) 2073-2080
67. Vincentelli R., Canaan S., Campanacci V., Valencia C., Maurin D., Frassinetti F., Scappucini-Calvo L., Bourne Y., Cambillau C., and Bignon C. High-throughput automated refolding screening of inclusion bodies. Protein Sci. 13 (2004) 2782-2792
68. Arvinte T., Bui T.T., Dahab A.A., Demeule B., Drake A.F., Elhag D., and King P. The multi-mode polarization modulation spectrometer: part 1: simultaneous detection of absorption, turbidity, and optical activity. Anal. Biochem. 332 (2004) 46-57
69. Jiskoot W., Hlady V., Naleway J.J., and Herron J.N. Application of fluorescence spectroscopy for determining the structure and function of proteins. Pharm. Biotechnol. 7 (1995) 1-63
70. Lakowicz J.R. Principles of Fluorescence Spectroscopy (1999), Kluwer Academic/Plenum Publishers, New York, Boston, Dordrecht, London, Moscow
71. Aucamp J.P., Cosme A.M., Lye G.J., and Dalby P.A. High-throughput measurement of protein stability in microtiter plates. Biotechnol. Bioeng. (2005)
72. Liu J., Tian J., He W., Xie J., Hu Z., and Chen X. Spectrofluorimetric study of the binding of daphnetin to bovine serum albumin. J. Pharm. Biomed. Anal. 35 (2004) 671-677
73. Silva D., Cortez C.M., and Louro S.R. Chlorpromazine interactions to sera albumins. A study by the quenching of fluorescence. Spectrochim. Acta A Mol. Biomol. Spectrosc. 60 (2004) 1215-1223
74. Naseem F., Khan R.H., Haq S.K., and Naeem A. Characterization of molten globule state of fetuin at low pH. Biochim. Biophys. Acta 1649 (2003) 164-170
75. Ali V., Prakash K., Kulkarni S., Ahmad A., Madhusudan K.P., and Bhakuni V. 8-anilino-1-naphthalene sulfonic acid (ANS) induces folding of acid unfolded cytochrome c to molten globule state as a result of electrostatic interactions. Biochemistry 38 (1999) 13635-13642
76. Haupts U., Rudiger M., Ashman S., Turconi S., Bingham R., Wharton C., Hutchinson J., Carey C., Moore K.J., and Pope A.J. Single-molecule detection technologies in miniaturized high-throughput screening: fluorescence intensity distribution analysis. J. Biomol. Screen. 8 (2003) 19-33
77. Zemanova L., Schenk A., Valler M.J., Nienhaus G.U., and Heilker R. Confocal optics microscopy for biochemical and cellular high-throughput screening. Drug Discov. Today 8 (2003) 1085-1093
78. Scheel A.A., Funsch B., Busch M., Gradl G., Pschorr J., and Lohse M.J. Receptor-ligand interactions studied with homogeneous fluorescence-based assays suitable for miniaturized screening. J. Biomol. Screen. 6 (2001) 11-18
79. Kask P., Palo K., Ullmann D., and Gall K. Fluorescence-intensity distribution analysis and its application in biomolecular detection technology. Proc. Natl. Acad. Sci. USA 96 (1999) 13756-13761
80. Jager S., Garbow N., Kirsch A., Preckel H., Gandenberger F.U., Herrenknecht K., Rudiger M., Hutchinson J.P., Bingham R.P., Ramon F., Bardera A., and Martin J. A modular, fully integrated ultra-high-throughput screening system based on confocal fluorescence analysis techniques. J. Biomol. Screen. 8 (2003) 648-659
81. Ramm P. Image-based screening: a technology in transition. Curr. Opin. Biotechnol. 16 (2005) 41-48
82. Boute N., Jockers R., and Issad T. The use of resonance energy transfer in high-throughput screening: BRET versus FRET. Trends Pharmacol. Sci. 23 (2002) 351-354
83. Bergendahl V., Heyduk T., and Burgess R.R. Luminescence resonance energy transfer-based high-throughput screening assay for inhibitors of essential protein-protein interactions in bacterial RNA polymerase. Appl. Environ. Microbiol. 69 (2003) 1492-1498
84. Moshinsky D.J., Ruslim L., Blake R.A., and Tang F. A widely applicable, high-throughput TR-FRET assay for the measurement of kinase autophosphorylation: VEGFR-2 as a prototype. J. Biomol. Screen. 8 (2003) 447-452
85. Goddard J.P., and Reymond J.L. Enzyme assays for high-throughput screening. Curr. Opin. Biotechnol. 15 (2004) 314-322
86. Eisenhawer M., Cattarinussi S., Kuhn A., and Vogel H. Fluorescence resonance energy transfer shows a close helix-helix distance in the transmembrane M13 procoat protein. Biochemistry 40 (2001) 12321-12328
87. Gonzalez-Jimenez J., and Cortijo M. Resonance energy transfer between tryptophan-214 in human serum albumin and acrylodan, prodan, and promen. Protein J. 23 (2004) 351-355
88. Owicki J.C. Fluorescence polarization and anisotropy in high throughput screening: perspectives and primer. J. Biomol. Screen. 5 (2000) 297-306
89. Jameson D.M., and Sawyer W.H. Fluorescence anisotropy applied to biomolecular interactions. Methods Enzymol. 246 (1995) 283-300
90. Jameson D.M., and Seifried S.E. Quantification of protein-protein interactions using fluorescence polarization. Methods 19 (1999) 222-233
91. Prystay L., Gosselin M., and Banks P. Determination of equilibrium dissociation constants in fluorescence polarization. J. Biomol. Screen. 6 (2001) 141-150
92. Turconi S., Shea K., Ashman S., Fantom K., Earnshaw D.L., Bingham R.P., Haupts U.M., Brown M.J., and Pope A.J. Real experiences of uHTS: a prototypic 1536-well fluorescence anisotropy-based uHTS screen and application of well-level quality control procedures. J. Biomol. Screen. 6 (2001) 275-290
93. Allen M., Reeves J., and Mellor G. High throughput fluorescence polarization: a homogeneous alternative to radioligand binding for cell surface receptors. J. Biomol. Screen. 5 (2000) 63-69
94. Capelle M.A.H., Brugger P., and Arvinte T. Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicity. Vaccine 23 (2005) 1686-1694
95. French T.E., Owicki J.C., Modlin D.N., Deshpande S.S., Mineyev I., Crawford K., and Burton W. Fluorescence-lifetime technologies for high-throughput screening. Proc. SPIE 3259 (1998) 209-218
96. Fowler A., Swift D., Longman E., Acornley A., Hemsley P., Murray D., Unitt J., Dale I., Sullivan E., and Coldwell M. An evaluation of fluorescence polarization and lifetime discriminated polarization for high throughput screening of serine/threonine kinases. Anal. Biochem. 308 (2002) 223-231
97. Turconi S., Bingham R.P., Haupts U., and Pope A.J. Developments in fluorescence lifetime-based analysis for ultra-HTS. Drug Discov. Today 6 (2001) S27-S39
98. Eggeling C., Brand L., Ullmann D., and Jager S. Highly sensitive fluorescence detection technology currently available for HTS. Drug Discov. Today 8 (2003) 632-641
99. Chen Y., and Barkley M.D. Toward understanding tryptophan fluorescence in proteins. Biochemistry 37 (1998) 9976-9982
100. Palo K., Brand L., Eggeling C., Jager S., Kask P., and Gall K. Fluorescence intensity and lifetime distribution analysis: toward higher accuracy in fluorescence fluctuation spectroscopy. Biophys. J. 83 (2002) 605-618
101. Wilson W.W. Light scattering as a diagnostic for protein crystal growth - a practical approach. J. Struct. Biol. 142 (2003) 56-65
102. Chen T.M., Shen H., and Zhu C. Evaluation of a method for high throughput solubility determination using a multi-wavelength UV plate reader. Comb. Chem. High Throughput Screen. 5 (2002) 575-581
103. Pan L., Ho Q., Tsutsui K., and Takahashi L. Comparison of chromatographic and spectroscopic methods used to rank compounds for aqueous solubility. J. Pharm. Sci. 90 (2001) 521-529
104. Smith A.M., Chan J., Oksenberg D., Urfer R., Wexler D.S., Ow A., Gao L., McAlorum A., and Huang S.G. A high-throughput turbidometric assay for screening inhibitors of protein disulfide isomerase activity. J. Biomol. Screen. 9 (2004) 614-620
105. Dehring K.A., Workman H.L., Miller K.D., Mandagere A., and Poole S.K. Automated robotic liquid handling/laser-based nephelometry system for high throughput measurement of kinetic aqueous solubility. J. Pharm. Biomed. Anal. 36 (2004) 447-456
106. Salzer R., Steiner G., Mantsch H.H., Mansfield J., and Lewis E.N. Infrared and Raman imaging of biological and biomimetic samples. Fresenius J. Anal. Chem. 366 (2000) 712-716
107. Adar F., Whitley A., and Geiger R. A raman microprobe optimized for microarrays and multiple-well plates. Am. Genomic/Proteomic Technol. 1 (2001) 44-48
108. Anquetil P.A., Brenan C.J., Marcolli C., and Hunter I.W. Laser Raman spectroscopic analysis of polymorphic forms in microliter fluid volumes. J. Pharm. Sci. 92 (2003) 149-160
109. Chi Z., Chen X.G., Holtz J.S., and Asher S.A. UV resonance Raman-selective amide vibrational enhancement: quantitative methodology for determining protein secondary structure. Biochemistry 37 (1998) 2854-2864
110. Ngarize S., Herman H., Adams A., and Howell N. Comparison of changes in the secondary structure of unheated, heated, and high-pressure-treated beta-lactoglobulin and ovalbumin proteins using Fourier-transform raman spectroscopy and self-deconvolution. J. Agric. Food Chem. 52 (2004) 6470-6477
111. Rousseau M.E., Lefevre T., Beaulieu L., Asakura T., and Pezolet M. Study of protein conformation and orientation in silkworm and spider silk fibers using Raman microspectroscopy. Biomacromolecules 5 (2004) 2247-2257
112. Sane S.U., Wong R., and Hsu C.C. Raman spectroscopic characterization of drying-induced structural changes in a therapeutic antibody: correlating structural changes with long-term stability. J. Pharm. Sci. 93 (2004) 1005-1018
113. Carpenter J.F., Prestrelski S.J., and Dong A. Application of infrared spectroscopy to development of stable lyophilized protein formulations. Eur. J. Pharm. Biopharm. 45 (1998) 231-238
114. Kubanek P., Busch O., Thomson S., Schmidt H.W., and Schuth F. Imaging reflection IR spectroscopy as a tool to achieve higher integration for high-throughput experimentation in catalysis research. J. Comb. Chem. 6 (2004) 420-425
115. van der Weerd J., and Kazarian S.G. Combined approach of FTIR imaging and conventional dissolution tests applied to drug release. J. Control. Release 98 (2004) 295-305
116. Chan K.L., and Kazarian S.G. Fourier transform infrared imaging for high-throughput analysis of pharmaceutical formulations. J. Comb. Chem. 7 (2005) 185-189
117. Goldberg M.E., and Chaffotte A.F. Undistorted structural analysis of soluble proteins by attenuated total reflectance infrared spectroscopy. Protein Sci. 14 (2005) 2781-2792
118. Tielmann P., Boese M., Luft M., and Reetz M.T. A practical high-throughput screening system for enantioselectivity by using FTIR spectroscopy. Chemistry 9 (2003) 3882-3887
119. Remmele Jr. R.L., Nightlinger N.S., Srinivasan S., and Gombotz W.R. Interleukin-1 receptor (IL-1R) liquid formulation development using differential scanning calorimetry. Pharm. Res. 15 (1998) 200-208
120. Remmele Jr. R.L., and Gombotz W.R. Differential scanning calorimetry: a practical tool for elucidating the stability of liquid biopharmaceuticals. BioPharm. Int. (2000) 36-46
121. Cueto M., Dorta M.J., Munguia O., and Llabres M. New approach to stability assessment of protein solution formulations by differential scanning calorimetry. Int. J. Pharm. 252 (2003) 159-166
122. Jelesarov I., and Bosshard H.R. Isothermal titration calorimetry and differential scanning calorimetry as complementary tools to investigate the energetics of biomolecular recognition. J. Mol. Recognit. 12 (1999) 3-18
123. Plotnikov V., Rochalski A., Brandts M., Brandts J.F., Williston S., Frasca V., and Lin L. An autosampling differential scanning calorimeter instrument for studying molecular interactions. Assay Drug Dev. Technol. 1 (2002) 83-89
124. Matulis D., Kranz J.K., Salemme F.R., and Todd M.J. Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using ThermoFluor. Biochemistry 44 (2005) 5258-5266
125. Huck C.W., Stecher G., Bakry R., and Bonn G.K. Recent progress in high-performance capillary bioseparations. Electrophoresis 24 (2003) 3977-3997
126. Valente J.J., Fryksdale B.G., Dale D.A., Gaertner A.L., and Henry C.S. Screening for physical stability of a Pseudomonas amylase using self-interaction chromatography. Anal. Biochem. (2006)
127. Yang X., Ma L., and Carr P.W. High temperature fast chromatography of proteins using a silica-based stationary phase with greatly enhanced low pH stability. J. Chromatogr. A 1079 (2005) 213-220
128. Wren S.A., and Tchelitcheff P. Use of ultra-performance liquid chromatography in pharmaceutical development. J. Chromatogr. A 1119 (2006) 140-146
129. Ros A., Faupel M., Mees H., Oostrum J., Ferrigno R., Reymond F., Michel P., Rossier J.S., and Girault H.H. Protein purification by Off-Gel electrophoresis. Proteomics. 2 (2002) 151-156
130. Michel P.E., Reymond F., Arnaud I.L., Josserand J., Girault H.H., and Rossier J.S. Protein fractionation in a multicompartment device using Off-Gel isoelectric focusing. Electrophoresis 24 (2003) 3-11
131. He Y., and Yeung E.S. High-throughput screening of kinase inhibitors by multiplex capillary electrophoresis with UV absorption detection. Electrophoresis 24 (2003) 101-108
132. Gong X., and Yeung E.S. An absorption detection approach for multiplexed capillary electrophoresis using a linear photodiode array. Anal. Chem. 71 (1999) 4989-4996
133. Emrich C.A., Tian H., Medintz I.L., and Mathies R.A. Microfabricated 384-lane capillary array electrophoresis bioanalyzer for ultrahigh-throughput genetic analysis. Anal. Chem. 74 (2002) 5076-5083
134. Pang H.M., Kenseth J., and Coldiron S. High-throughput multiplexed capillary electrophoresis in drug discovery. Drug Discov. Today 9 (2004) 1072-1080
135. Kang S.H., Gong X., and Yeung E.S. High-throughput comprehensive peptide mapping of proteins by multiplexed capillary electrophoresis. Anal. Chem. 72 (2000) 3014-3021
136. Kenseth J.R., He Y., Tallman D., Pang H.M., and Coldiron S.J. Techniques for high-throughput characterization of peptides, oligonucleotides and catalysis efficiency. Curr. Opin. Chem. Biol. 8 (2004) 327-333
137. Berna M., Murphy A.T., Wilken B., and Ackermann B. Collection, storage, and filtration of in vivo study samples using 96-well filter plates to facilitate automated sample preparation and LC/MS/MS analysis. Anal. Chem. 74 (2002) 1197-1201
138. Zhang B., Foret F., and Karger B.L. High-throughput microfabricated CE/ESI-MS: automated sampling from a microwell plate. Anal. Chem. 73 (2001) 2675-2681
139. Hail M.E., Elliott B., and Anderson J. High-throughput analysis of oligonucleotides using automated electrospray ionization mass spectrometry. Am. Biotech. Lab. 22 (2004) 12-14
140. Kiernan U.A., Tubbs K.A., Gruber K., Nedelkov D., Niederkofler E.E., Williams P., and Nelson R.W. High-throughput protein characterization using mass spectrometric immunoassay. Anal. Biochem. 301 (2002) 49-56
141. Dubost D.C., Kaufman M.J., Zimmerman J.A., Bogusky M.J., Coddington A.B., and Pitzenberger S.M. Characterization of a solid state reaction product from a lyophilized formulation of a cyclic heptapeptide. A novel example of an excipient-induced oxidation. Pharm. Res. 13 (1996) 1811-1814
142. Bouvier A., Chapline J., Boerner R., Jeyarajah S., Cook S., Acharya P.S., Henderson I., Schrimsher J.L., and Shepard S.R. Identifying and modulating disulfide formation in the biopharmaceutical production of a recombinant protein vaccine candidate. J. Biotechnol. 103 (2003) 257-271
143. Jancarik J., Pufan R., Hong C., Kim S.H., and Kim R. Optimum solubility (OS) screening: an efficient method to optimize buffer conditions for homogeneity and crystallization of proteins. Acta Crystallogr. D Biol. Crystallogr. 60 (2004) 1670-1673
144. Segelke B.W. Efficiency analysis of sampling protocols used in protein crystallization screening. J. Cryst. Growth 232 (2001) 553-562
145. Hui R., and Edwards A. High-throughput protein crystallization. J. Struct. Biol. 142 (2003) 154-161
146. Delucas L.J., Hamrick D., Cosenza L., Nagy L., McCombs D., Bray T., Chait A., Stoops B., Belgovskiy A., William W.W., Parham M., and Chernov N. Protein crystallization: virtual screening and optimization. Prog. Biophys. Mol. Biol. 88 (2005) 285-309
147. Hosfield D., Palan J., Hilgers M., Scheibe D., McRee D.E., and Stevens R.C. A fully integrated protein crystallization platform for small-molecule drug discovery. J. Struct. Biol. 142 (2003) 207-217
148. Abola E., Kuhn P., Earnest T., and Stevens R.C. Automation of X-ray crystallography. Nat. Struct. Biol. 7 Suppl. (2000) 973-977
149. Pusey M.L., Liu Z.J., Tempel W., Praissman J., Lin D., Wang B.C., Gavira J.A., and Ng J.D. Life in the fast lane for protein crystallization and X-ray crystallography. Prog. Biophys. Mol. Biol. 88 (2005) 359-386
150. P. Mittl, M. Grütter, T. Arvinte, Transforming growth factor beta crystals, Switzerland Patent WO 97/05166 (1997).
151. Hung L.H., and Samudrala R. PROTINFO: secondary and tertiary protein structure prediction. Nucleic Acids Res. 31 (2003) 3296-3299
152. Merchant M. More virtual, more throughput, more smaller, more better?. Drug Discov. Today 8 (2003) 532-534
153. Bajorath J. Integration of virtual and high-throughput screening. Nat. Rev. Drug Discov. 1 (2002) 882-894
154. Arvinte T., Cudd A., and Drake A.F. The structure and mechanism of formation of human calcitonin fibrils. J. Biol. Chem. 268 (1993) 6415-6422
155. Gribbon P., and Sewing A. Fluorescence readouts in HTS: no gain without pain?. Drug Discov. Today 8 (2003) 1035-1043
156. Helfrich J.P., and Jones W.R. High-throughput flow-injection technique for stability sensing characterization of biomolecules in solution. American Laboratory (Shelton, CT, United States) 33 (2001) 24-29
157. Di L., Kerns E.H., Chen H., and Petusky S.L. Development and application of an automated solution stability assay for drug discovery. J. Biomol. Screen. (2005) 40-47
158. Zehender H., Le Goff F., Lehmann N., Filipuzzi I., and Mayr L.M. SpeedScreen: the "missing link" between genomics and lead discovery. J. Biomol. Screen. 9 (2004) 498-505
159. Guy R.L., Gonias L.A., and Stein M.A. A fluorescence microscopy based genetic screen to identify mutants altered for interactions with host cells. J. Microbiol. Methods 42 (2000) 129-138
160. Li Z., Yan Y., Powers E.A., Ying X., Janjua K., Garyantes T., and Baron B. Identification of gap junction blockers using automated fluorescence microscopy imaging. J. Biomol. Screen. 8 (2003) 489-499
161. Galvao-Botton L.M., Katsuyama A.M., Guzzo C.R., Almeida F.C., Farah C.S., and Valente A.P. High-throughput screening of structural proteomics targets using NMR. FEBS Lett. 552 (2003) 207-213
162. Coles M., Heller M., and Kessler H. NMR-based screening technologies. Drug Discov. Today 8 (2003) 803-810
163. Wilson S., and Howell S. High-throughput screening in the diagnostics industry. Biochem. Soc. Trans. 30 (2002) 794-797
164. Jones D.B., Hutchinson M.H., and Middelberg A.P. Screening protein refolding using surface plasmon resonance. Proteomics 4 (2004) 1007-1013
165. Marziali A., Willis T.D., and Davis R.W. An arrayable flow-through microcentrifuge for high-throughput instrumentation. Proc. Natl. Acad. Sci. USA 96 (1999) 61-66
166. Laue T.M. An arrayable flow-through microcentrifuge for high-throughput instrumentation-a matter of scale. Proc. Natl. Acad. Sci. USA 96 (1999) 1163